# Control of Iatrogenic Endobronchial Bleeding by Tranexamic Acid, Adrenalin and Hemagglutinase

> **NCT06149091** · EARLY_PHASE1 · UNKNOWN · sponsor: **China-Japan Friendship Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Iatrogenic Endobronchial Bleeding

## Interventions

- **DRUG:** Tranexamic Acid；
- **DRUG:** Adrenalin
- **DRUG:** Hemagglutinase

## Key facts

- **NCT ID:** NCT06149091
- **Lead sponsor:** China-Japan Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-11-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06149091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06149091, "Control of Iatrogenic Endobronchial Bleeding by Tranexamic Acid, Adrenalin and Hemagglutinase". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06149091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*